Inventor · disambiguated record
Fahar Merchant
Also filed as: MERCHANT FAHAR
15 granted patents·11 pending applications·115 citations·filing 2000–2023
92Inventor score
Files withMEDICENNA THERAPEUTICS INC18MERCHANT FAHAR3AMERSHAM HEALTH AS2GE HEALTHCARE AS2UNIV LELAND STANFORD JUNIOR1
Top patents by PatentIndex Score
26 records- 0194US6689871B1Process for production diphtheria toxinAMERSHAM HEALTH AS·Filed 2000·Granted Feb 10, 2004·73 cites·10 claims
- 0293US11680090B2Interleukin-2 fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2020·Granted Jun 20, 2023·3 cites·17 claims
- 0388US10093708B2Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2014·Granted Oct 9, 2018·9 cites·19 claims
- 0487US10106592B2Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2014·Granted Oct 23, 2018·8 cites·16 claims
- 0586US10781242B2Interleukin-2 fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2014·Granted Sep 22, 2020·5 cites·28 claims
- 0682US11084856B2Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2018·Granted Aug 10, 2021·1 cites·12 claims
- 0782US7273728B2Process for production diphtheria toxinGE HEALTHCARE AS·Filed 2005·Granted Sep 25, 2007·5 cites·1 claims
- 0881US6962803B2Process for production diphtheria toxinAMERSHAM HEALTH AS·Filed 2003·Granted Nov 8, 2005·6 cites·10 claims
- 0980US11542312B2IL-2 superagonists in combination with anti-PD-1 antibodiesMEDICENNA THERAPEUTICS INC·Filed 2018·Granted Jan 3, 2023·1 cites·15 claims
- 1080US7575891B2Process for production of diphtheria toxinGE HEALTHCARE AS·Filed 2007·Granted Aug 18, 2009·4 cites·2 claims
- 1179US12503496B2Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2022·Granted Dec 23, 2025·0 cites·12 claims
- 1277US12338269B2IL-2 superagonists in combination with anti-PD-1 antibodiesMEDICENNA THERAPEUTICS INC·Filed 2022·Granted Jun 24, 2025·0 cites·10 claims
- 1375US2024067689A1Interleukin-2 fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1473US2022048965A1Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1572US2011171219A1Treating cancer stem cells using targeted cargo proteinsMERCHANT FAHAR·Filed 2009·Application pending·0 cites
- 1670US11352402B2Interleukin-4 receptor-binding fusion proteins and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2018·Granted Jun 7, 2022·0 cites·16 claims
- 1762US2025387474A1Uses and methods for il-2, il-13, and il-4 cytokine bifunctional moleculesMEDICENNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1862US2014193358A1Treating cancer stem cells using targeted cargo proteinsMERCHANT FAHAR·Filed 2013·Application pending·0 cites
- 1960US12404497B2Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereofMEDICENNA THERAPEUTICS INC·Filed 2019·Granted Sep 2, 2025·0 cites·11 claims
- 2056US2023405115A1Combination therapy of mdna55 and a vascular endothelial growth factor a (vegf-a)MEDICENNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2156US2016271231A1Treating cancer stem cells using targeted cargo proteinsMEDICENNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2255US2023365642A1Bifunctional superkines and uses thereofMEDICENNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2354US12274735B2IL-4-fusion formulations for treatment of central nervous system (CNS) tumorsMEDICENNA THERAPEUTICS INC·Filed 2018·Granted Apr 15, 2025·0 cites·20 claims
- 2447US2022347268A1Il-4r as a biomarker in cancerMEDICENNA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2545US2020095301A1Il-13 superkine: immune cell targeting constructs and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2017·Application pending·0 cites
- 2637US2016354472A1Use of human serum albumin to decrease antigenicity of therapeutic proteinsMERCHANT FAHAR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fahar Merchant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →